{"id":147378,"date":"2023-05-26T07:06:09","date_gmt":"2023-05-26T11:06:09","guid":{"rendered":"https:\/\/44.250.171.167\/?p=147378"},"modified":"2023-05-26T07:06:10","modified_gmt":"2023-05-26T11:06:10","slug":"sun-pharmaceuticals-ltd-q4fy23-results-out-revenue-grows-by-16","status":"publish","type":"post","link":"https:\/\/alphastreet.com\/india\/sun-pharmaceuticals-ltd-q4fy23-results-out-revenue-grows-by-16\/","title":{"rendered":"Sun Pharmaceuticals Ltd Q4FY23 results out, revenue grows by 16%"},"content":{"rendered":"\n<p>Sun Pharmaceuticals Ltd reported Total revenue for Q4 FY23 of \u20b910,931 Crore, up from \u20b99,447 Crore year on year depicting a growth of 16%. Consolidated Net Profit of \u20b91,984 Crore, up 187% from -(\u20b92,227) Crore in the same quarter of the previous year.\u00a0The Earnings per Share is \u20b98.3, up 187% from -(\u20b99.49) in the same quarter of the previous year.<\/p>\n\n\n\n<figure class=\"wp-block-image size-large\"><img loading=\"lazy\" decoding=\"async\" width=\"831\" height=\"1024\" src=\"https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2023\/05\/6eaa6fbf-2dda-4b37-9c1c-097089b9107b-831x1024.png\" alt=\"\" class=\"wp-image-147379\" srcset=\"https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2023\/05\/6eaa6fbf-2dda-4b37-9c1c-097089b9107b-831x1024.png 831w, https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2023\/05\/6eaa6fbf-2dda-4b37-9c1c-097089b9107b-244x300.png 244w, https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2023\/05\/6eaa6fbf-2dda-4b37-9c1c-097089b9107b-768x946.png 768w, https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2023\/05\/6eaa6fbf-2dda-4b37-9c1c-097089b9107b-1247x1536.png 1247w, https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2023\/05\/6eaa6fbf-2dda-4b37-9c1c-097089b9107b-1663x2048.png 1663w\" sizes=\"auto, (max-width: 831px) 100vw, 831px\" \/><\/figure>\n","protected":false},"excerpt":{"rendered":"<p>Sun Pharmaceuticals Ltd reported Total revenue for Q4 FY23 of \u20b910,931 Crore, up from \u20b99,447 Crore year on year depicting a growth of 16%. Consolidated Net Profit of \u20b91,984 Crore, up 187% from -(\u20b92,227) Crore in the same quarter of the previous year.\u00a0The Earnings per Share is \u20b98.3, up 187% from -(\u20b99.49) in the same [&hellip;]<\/p>\n","protected":false},"author":1863,"featured_media":147379,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"jetpack_post_was_ever_published":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[105,392,5747],"tags":[10304,10442,1115],"class_list":["post-147378","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-infographics","category-earnings","category-healthcare-stocks","tag-api","tag-cdmo","tag-pharmaceuticals"],"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2023\/05\/6eaa6fbf-2dda-4b37-9c1c-097089b9107b.png","jetpack_likes_enabled":false,"jetpack-related-posts":[{"id":147571,"url":"https:\/\/alphastreet.com\/india\/torrent-pharmaceuticals-ltd-q4fy23-revenue-grows-by-17\/","url_meta":{"origin":147378,"position":0},"title":"Torrent Pharmaceuticals Ltd Q4FY23 revenue grows by 17%","author":"Chirag Gupta","date":"May 30, 2023","format":false,"excerpt":"Torrent Pharmaceuticals Ltd reported Total revenue for Q4 FY23 of \u20b92,452 Crore, up from \u20b9 Crore year on year depicting a growth of 17%. Consolidated Net Profit of \u20b9287 Crore, up 343% from -(\u20b9118) Crore in the same quarter of the previous year. The Earnings per Share is \u20b98.48, up\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/05\/aaf214f9-9299-4354-adcf-b4303477732d.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/05\/aaf214f9-9299-4354-adcf-b4303477732d.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/05\/aaf214f9-9299-4354-adcf-b4303477732d.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/05\/aaf214f9-9299-4354-adcf-b4303477732d.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/05\/aaf214f9-9299-4354-adcf-b4303477732d.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/05\/aaf214f9-9299-4354-adcf-b4303477732d.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":147000,"url":"https:\/\/alphastreet.com\/india\/sun-pharma-advanced-research-company-q4fy23-results-out-revenue-grows-by-92\/","url_meta":{"origin":147378,"position":1},"title":"Sun Pharma Advanced Research Company Q4FY23 results out, revenue grows by 92%","author":"Chirag Gupta","date":"May 22, 2023","format":false,"excerpt":"Sun Pharma Advanced Research Company Ltd is engaged in the business of research and development (R&D) of pharmaceutical products. The company is a clinical stage bio-pharmaceutical company and earns its revenues from license fee\/ royalty on technology and R&D services. Sun Pharma Advanced Research Company reported Total revenue for Q4\u2026","rel":"","context":"In &quot;Earnings&quot;","block_context":{"text":"Earnings","link":"https:\/\/alphastreet.com\/india\/category\/earnings\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2021\/10\/Earnings-Coverage.jpg?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2021\/10\/Earnings-Coverage.jpg?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2021\/10\/Earnings-Coverage.jpg?resize=525%2C300&ssl=1 1.5x"},"classes":[]},{"id":169156,"url":"https:\/\/alphastreet.com\/india\/glenmark-pharmaceuticals-ltd-q4fy25-6-rise-in-revenue\/","url_meta":{"origin":147378,"position":2},"title":"Glenmark Pharmaceuticals Ltd Q4FY25; 6% rise in Revenue","author":"Divyansh_Kasana","date":"July 16, 2025","format":false,"excerpt":"Glenmark Pharmaceuticals Ltd is a global research-led pharmaceutical company with presence across generics, Specialty and OTC business with operations in over 80 countries. Financial Results: Glenmark Pharmaceuticals Ltd reported Revenues for Q4FY25 of \u20b93,256.20 Crores up from \u20b93,062.96 Crore year on year, a rise of 6.31%. Total Expenses for Q4FY25\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/07\/Y.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/07\/Y.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/07\/Y.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/07\/Y.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/07\/Y.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/07\/Y.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":147287,"url":"https:\/\/alphastreet.com\/india\/suven-pharmaceuticals-ltd-q4fy23-results-out-net-profit-grows-by-35\/","url_meta":{"origin":147378,"position":3},"title":"Suven Pharmaceuticals Ltd Q4FY23 results out, net profit grows by 35%","author":"Chirag Gupta","date":"May 25, 2023","format":false,"excerpt":"Suven Pharma is in the business of Contract development & manufacturing organisation (CDMO), catering to the needs of global Pharma Industry. SPL engages in NCE molecule development and supply of intermediates. This is a high-value-add, high-margin business. SPL supplies intermediates for four molecules addressing rheumatoid arthritis, diabetes, depression and women\u2019s\u2026","rel":"","context":"In &quot;Earnings&quot;","block_context":{"text":"Earnings","link":"https:\/\/alphastreet.com\/india\/category\/earnings\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2021\/10\/Earnings-Coverage.jpg?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2021\/10\/Earnings-Coverage.jpg?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2021\/10\/Earnings-Coverage.jpg?resize=525%2C300&ssl=1 1.5x"},"classes":[]},{"id":169169,"url":"https:\/\/alphastreet.com\/india\/glenmark-pharmaceuticals-ltd-q4fy25-6-rise-in-revenue-2\/","url_meta":{"origin":147378,"position":4},"title":"Glenmark Pharmaceuticals Ltd Q4FY25; 6% rise in Revenue","author":"Divyansh_Kasana","date":"July 17, 2025","format":false,"excerpt":"Glenmark Pharmaceuticals Ltd is a global research-led pharmaceutical company with presence across generics, Specialty and OTC business with operations in over 80 countries. Financial Results: Glenmark Pharmaceuticals Ltd reported Revenues for Q4FY25 of \u20b93,256.20 Crores up from \u20b93,062.96 Crore year on year, a rise of 6.31%. Total Expenses for Q4FY25\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/07\/U-11.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/07\/U-11.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/07\/U-11.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/07\/U-11.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/07\/U-11.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/07\/U-11.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":154288,"url":"https:\/\/alphastreet.com\/india\/balaxi-pharmaceuticals-ltd-q1fy24-20-fall-in-revenue\/","url_meta":{"origin":147378,"position":5},"title":"Balaxi Pharmaceuticals Ltd Q1FY24; 20% fall in Revenue","author":"Divyansh_Kasana","date":"August 17, 2023","format":false,"excerpt":"Balaxi Pharmaceuticals Ltd is an IPR-based pharmaceutical Company engaged in producing, stocking, selling, and supplying branded and generic medicines. Financial Results: Balaxi Pharmaceuticals Ltd reported Revenues for Q1FY24 of \u20b966.00 Crores down from \u20b983.00 Crore year on year, a fall of 20.48%. Total Expenses for Q1FY24 of \u20b957.00 Crores down\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-1194.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-1194.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-1194.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-1194.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-1194.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-1194.png?resize=1400%2C800&ssl=1 4x"},"classes":[]}],"jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts\/147378","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/users\/1863"}],"replies":[{"embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/comments?post=147378"}],"version-history":[{"count":0,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts\/147378\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/media\/147379"}],"wp:attachment":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/media?parent=147378"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/categories?post=147378"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/tags?post=147378"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}